These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30361472)

  • 1. [Content of official addressed to women informative documents about breast cancer screening in Spain].
    Ballesteros-Peña S; Gavilán-Moral E
    Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30361472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial.
    Carles M; Martínez-Alonso M; Pons A; Pérez-Lacasta MJ; Perestelo-Pérez L; Sala M; Vidal C; Garcia M; Toledo-Chávarri A; Codern N; Feijoo-Cid M; Romero A; Pla R; Soler-González J; Castells X; Rué M;
    Trials; 2017 Sep; 18(1):426. PubMed ID: 28899412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Elements of Mammography Shared Decision-Making: a Scoping Review of the Literature.
    DuBenske LL; Schrager SB; Hitchcock ME; Kane AK; Little TA; McDowell HE; Burnside ES
    J Gen Intern Med; 2018 Oct; 33(10):1805-1814. PubMed ID: 30030738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of extending screening mammography to older women: Information to support informed choices.
    Jacklyn G; Howard K; Irwig L; Houssami N; Hersch J; Barratt A
    Int J Cancer; 2017 Oct; 141(8):1540-1550. PubMed ID: 28662267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial.
    Hersch J; Barratt A; Jansen J; Houssami N; Irwig L; Jacklyn G; Dhillon H; Thornton H; McGeechan K; Howard K; McCaffery K
    BMJ Open; 2014 May; 4(5):e004990. PubMed ID: 24833692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Online information about mammography screening in Italy from 2014 to 2021.
    Attena F; Abagnale L; Avitabile A
    BMC Womens Health; 2022 Apr; 22(1):132. PubMed ID: 35477449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial.
    Pérez-Lacasta MJ; Martínez-Alonso M; Garcia M; Sala M; Perestelo-Pérez L; Vidal C; Codern-Bové N; Feijoo-Cid M; Toledo-Chávarri A; Cardona À; Pons A; Carles-Lavila M; Rue M;
    PLoS One; 2019; 14(3):e0214057. PubMed ID: 30913217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in false-positive results after introduction of digital mammography: analysis from four population-based breast cancer screening programs in Spain.
    Sala M; Salas D; Belvis F; Sánchez M; Ferrer J; Ibañez J; Román R; Ferrer F; Vega A; Laso MS; Castells X
    Radiology; 2011 Feb; 258(2):388-95. PubMed ID: 21273520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial.
    Hersch J; McGeechan K; Barratt A; Jansen J; Irwig L; Jacklyn G; Houssami N; Dhillon H; McCaffery K
    BMJ Open; 2017 Oct; 7(10):e016246. PubMed ID: 28988168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.
    Hersch J; Barratt A; Jansen J; Irwig L; McGeechan K; Jacklyn G; Thornton H; Dhillon H; Houssami N; McCaffery K
    Lancet; 2015 Apr; 385(9978):1642-52. PubMed ID: 25701273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of intermediate mammography assessment on the likelihood of false-positive results in breast cancer screening programmes.
    Ascunce N; Ederra M; Delfrade J; Baroja A; Erdozain N; Zubizarreta R; Salas D; Castells X;
    Eur Radiol; 2012 Feb; 22(2):331-40. PubMed ID: 21901564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from the Swiss Medical Board recommendation against mammography screening programs.
    Chiolero A; Rodondi N
    JAMA Intern Med; 2014 Oct; 174(10):1541-2. PubMed ID: 25154463
    [No Abstract]   [Full Text] [Related]  

  • 14. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study.
    Otten JDM; Fracheboud J; den Heeten GJ; Otto SJ; Holland R; de Koning HJ; Broeders MJM; Verbeek ALM
    Ann Oncol; 2013 Oct; 24(10):2501-2506. PubMed ID: 23788759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uninformed compliance or informed choice? A needed shift in our approach to cancer screening.
    Stefanek ME
    J Natl Cancer Inst; 2011 Dec; 103(24):1821-6. PubMed ID: 22106094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of research in breast cancer screening in Spain: implications for prevention].
    Sala M; Salas D; Zubizarreta R; Ascunce N; Rué M; Castells X;
    Gac Sanit; 2012; 26(6):574-81. PubMed ID: 22424970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconceptions influence women's perceptions of information on breast cancer screening: a qualitative study.
    Henriksen MJ; Guassora AD; Brodersen J
    BMC Res Notes; 2015 Sep; 8():404. PubMed ID: 26336075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are women getting relevant information about mammography screening for an informed consent: a critical appraisal of information brochures used for screening invitation in Germany, Italy, Spain and France.
    Gummersbach E; Piccoliori G; Zerbe CO; Altiner A; Othman C; Rose C; Abholz HH
    Eur J Public Health; 2010 Aug; 20(4):409-14. PubMed ID: 19892852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.